ST LOUIS: Cerebrospinal fluid (CSF) levels of a certain brain protein may be a helpful predictor of progression to Alzheimer’s disease, researchers found.

In a single-centre, case-control trial, CSF levels of VILIP-1 predicted rates of whole-brain and regional atrophy similarly to tau and p-tau181.

The Read More »

TUCSON: As the senior care industry gains more traction amongst both veteran and fledgling tech companies, one startup is poised to take the aging services sector by storm.

It’s using 3-D bioprinting technology to create living tissues that can be used for testing new drugs Read More »

HOUSTON: Dementia research gets 13 times less funding than cancer even though the cost to society is far greater, a university has found.

Yet despite the huge burden of dementia, just 8 cents is spent on researching new treatments for each $10 spent looking after Read More »

HOUSTON: Drug trials are now under way, aimed at potentially slowing or even stopping the progression of Alzheimer’s disease.

The trials are also aimed at preventing dementia from Alzheimer’s disease developing in the first place.

While there is no cure for this progressive form of Read More »